Início › Artrite Psoriásica › Texas
Ensaios clínicos de Artrite Psoriásica em Texas
17 estudos para Artrite Psoriásica estão buscando participantes em locais em Texas.
Cidades em Texas
- Houston8 estudos
- Baytown4 estudos
- Dallas4 estudos
- The Woodlands4 estudos
- Arlington4 estudos
- Lubbock3 estudos
- Mesquite3 estudos
- Fort Worth3 estudos
- Austin3 estudos
Texto oficial do estudo (Inglês)
A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis
- UT Southwestern, Dallas
- Arthritis and Rheumatology Research Institute, Frisco
- AARA Clinical Research Lone Star Arthritis and Rheumatology, Irving
- e mais 2
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06807424A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
- Cook Childrens Medical Center, Fort Worth
RecrutandoFase 3
Idades 3 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06663332A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis
- Arthritis and Rheumatology Research Institute, Frisco
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07321873A Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Moderate to Severe Psoriatic Arthritis
- Precision Comprehensive Research, Colleyville
- Rheumatology Associates of South Texas, San Antonio
RecrutandoFase 2
Idades de 18 a 100 · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07801495Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
- UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
- e mais 2
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT03816345A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
- Accurate Clinical Research, Baytown
- Novel Research | Bellaire Location, Bellaire
- Novel Research | Bellaire Location, Bellaire
- e mais 5
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 17 de set. de 2026 · NCT06671483Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)
- Greater Houston Rheumatology ( Site 5103), Houston
RecrutandoFase 2
Idades de 18 a 80 · Todos os sexos · Atualizado em 14 de set. de 2026 · NCT07486960Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response
- Clinical Site, Austin
- Clinical Site, Baytown
- Clinical Site, Colleyville
- e mais 1
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 11 de set. de 2026 · NCT06641089A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
- AARR- Lone Star Arthritis & Rheumatology Associates, Fort Worth
- Biopharma Informatic | Hassan, Houston
- Advanced Rheumatology of Houston - The Woodlands, The Woodlands
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 9 de set. de 2026 · NCT06671496Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
- Accurate Clinical Research, Baytown
- Novel Research LLC, Bellaire
- Novel Research | Abigail Neiman - Houston, TX, Houston
- e mais 4
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 9 de set. de 2026 · NCT07286058Deucravacitinib-TNFi Combination Therapy for Difficult-to-Control Psoriatic Disease
- UT Southwestern Medical Center, Dallas
RecrutandoFase 4
Idades de 18 a 65 · Todos os sexos · Atualizado em 1 de set. de 2026 · NCT07280702A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
- Child Neurology Consultants of Austin /ID# 260562, Austin
RecrutandoFase 3
Idades de 5 a 17 · Todos os sexos · Atualizado em 1 de set. de 2026 · NCT06100744Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
- University of Texas Southwestern Medical Center Dallas, Dallas
- Baylor College of Medicine Pediatric Immunology Allergy Rheumatology, Houston
RecrutandoEstudo observacional
Até 21 anos · Todos os sexos · Atualizado em 27 de ago. de 2026 · NCT02418442A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
- Pa0019 129, Baytown
- Pa0019 136, Colleyville
- Pa0019 135, Mesquite
- e mais 1
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 6 de jul. de 2026 · NCT07290036Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
- M D Anderson Cancer Center, Houston
RecrutandoEstudo observacional
Idades 18 e acima · Todos os sexos · Atualizado em 20 de mai. de 2026 · NCT04751396Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis
- Tekton Research - West Gate /ID# 272765, Austin
- Accurate Clinical Research - Houston /ID# 272754, Houston
- Tekton Research, LLC /ID# 272901, San Antonio
- e mais 1
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 18 de dez. de 2025 · NCT06865105Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients
- Heritage Rheumatology and Arthritis Care, Colleyville
- Texas Arthritis Center, El Paso
RecrutandoFase 3
Idades de 18 a 80 · Todos os sexos · Atualizado em 9 de out. de 2025 · NCT05669833Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.